Medtronic plc. vs Stryker Corporation
A head-to-head of Medtronic plc. (MDT) and Stryker Corporation (SYK) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | MDT | SYK |
|---|---|---|
| Market Cap | $106.50B | $122.63B |
| P/E (TTM) | 22.31 | 37.02 |
| Forward P/E | 12.38 | 18.74 |
| P/S | 2.83 | 4.75 |
| P/B | 2.13 | 5.34 |
| EV/EBITDA | 12.19 | 18.77 |
| Dividend Yield | 3.42% | 1.06% |
| Profit Margin | 13.20% | 13.21% |
| Gross Margin | 65.02% | 63.96% |
| Operating Margin | 18.78% | 20.14% |
| Revenue Growth (YoY) | +9.86% | +2.63% |
| FCF Yield | 5.25% | 3.81% |
| Debt / Equity | 55.72 | 64.07 |
| Current Ratio | 2.13 | 2.11 |
Which is better: Medtronic plc. or Stryker Corporation?
- ✓Larger by market cap: Stryker Corporation
- ✓Cheaper valuation (lower P/E): Medtronic plc.
- ✓Higher dividend yield: Medtronic plc.
- ✓More profitable (net margin): Stryker Corporation
- ✓Faster revenue growth: Medtronic plc.
- ✓Higher free-cash-flow yield: Medtronic plc.
Across 13 available metrics, Medtronic plc. leads 11–2.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.